Blakeley John 4
4 · ERESEARCHTECHNOLOGY INC /DE/ · Filed Mar 1, 2010
Insider Transaction Report
Form 4
Blakeley John
Exec V.P., Sales & Marketing
Transactions
- Award
Option (Right to Buy)
2010-02-26$6.05/sh+26,895$162,715→ 26,895 totalExercise: $6.05Exp: 2017-02-26→ Common Stock, $.01 par value (26,895 underlying) - Award
Common Stock, $.01 par value
2010-02-26+12,848→ 12,848 total
Holdings
- 2,025
Option (Right to Buy)
Exercise: $3.01Exp: 2012-07-23→ Common Stock, $.01 par value (2,025 underlying) - 25,000
Option (Right to Buy)
Exercise: $12.00Exp: 2015-02-28→ Common Stock, $.01 par value (25,000 underlying) - 20,000
Option (Right to Buy)
Exercise: $7.41Exp: 2014-02-23→ Common Stock, $.01 par value (20,000 underlying) - 5,000
Option (Right to Buy)
Exercise: $14.70Exp: 2013-02-10→ Common Stock, $.01 par value (5,000 underlying) - 10,000
Option (Right to Buy)
Exercise: $15.46Exp: 2012-02-14→ Common Stock, $.01 par value (10,000 underlying) - 50,000
Option (Right to Buy)
Exercise: $4.60Exp: 2016-03-02→ Common Stock, $.01 par value (50,000 underlying) - 300
Options (Right to Buy)
Exercise: $22.09Exp: 2014-02-09→ Common Stock, $.01 par value (300 underlying)
Footnotes (4)
- [F1]Represents a restricted stock grant that vests in four equal annual installments beginning one year after date of grant.
- [F2]Options become exercisable in four equal annual installments beginning one year after date of grant and are fully exercisable three years prior to expiration.
- [F3]25% of the total options granted became exercisable one year after date of grant. The remaining 75% become exercisable in December 2005.
- [F4]Options become exercisable in four equal annual installments beginning one year after date of grant and are fully exercisable six years prior to expiration